This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Genoscience Pharma. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Clarisse Dubray: Innovator in Anticancer Agents
Introduction
Clarisse Dubray is a prominent inventor based in Aix-en-Provence, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of new anticancer agents. Her innovative work focuses on novel compounds that have the potential to treat various diseases.
Latest Patents
Clarisse holds a patent for "Substituted 2,4 diamino-quinoline as new anticancer agents." This invention relates to novel 2-primary amino-4-secondary amino-quinoline derivatives, their manufacture, pharmaceutical compositions comprising them, and their use as medicaments. The active compounds of this invention are useful for the treatment and prevention of proliferative neoplastic and non-neoplastic diseases. She has 1 patent to her name.
Career Highlights
Clarisse Dubray is associated with Genoscience Pharma, where she continues to work on groundbreaking research in the pharmaceutical industry. Her dedication to innovation has positioned her as a key player in the development of effective treatments for cancer.
Collaborations
Some of her notable coworkers include Firas Bassissi and Antoine Beret, who collaborate with her on various projects within the company.
Conclusion
Clarisse Dubray's contributions to the field of anticancer research exemplify her commitment to innovation and improving healthcare outcomes. Her work continues to inspire future advancements in the pharmaceutical industry.